Increased risk of Pneumocystis carinii and community-acquired pneumonia with tobacco use in HIV disease Article

Miguez-Burbano, MJ, Ashkin, D, Rodriguez, A et al. (2005). Increased risk of Pneumocystis carinii and community-acquired pneumonia with tobacco use in HIV disease . INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 9(4), 208-217. 10.1016/j.ijid.2004.07.010

cited authors

  • Miguez-Burbano, MJ; Ashkin, D; Rodriguez, A; Duncan, R; Pitchenik, A; Quintero, N; Flores, M; Shor-Posner, G


  • Objectives: Tobacco smoking-related diseases continue to be of great health concern for the public, in general, and may be particularly deleterious for immunosuppressed HIV-positive individuals, who exhibit widespread tobacco use. Methods: A total of 521 HIV-infected subjects consecutively admitted to Jackson Memorial Hospital between 2001-2002 were enrolled in the study. Research data included a medical history, details of tobacco and illicit drug use and complete computerized hospital information. Blood was drawn to obtain T lymphocyte profiles and viral load levels. Statistical analysis methods included Pearson, Student's t- and Chi-square tests and SAS Proc CATMOD. Results: Tobacco use was prevalent, with 65% of the 521 HIV-positive hospitalized patients being current smokers. Overall, current tobacco users reported smoking an average of 15 ± 13 cigarettes per day for an average of 15 ± 14 years, with 40% smoking more than one pack per day. Pulmonary infections accounted for 49% of the total hospital admissions: 52% bacterial pneumonias, 24% Pneumocystis carinii pneumonia (PCP), 12% non-tuberculous mycobacterial diseases (NTM), 11% tuberculosis and 1% bronchitis. Many of the respiratory patients (46%) had been on highly active antiretroviral therapy (HAART) for over six months and 42% had received PCP and/or NTM prophylaxis. After matching the cases by HAART and CDC stage, the hazardous risk of being hospitalized with a respiratory infection was significantly higher for smokers than non-smokers (95% CI 1.33-2.83; p = 0.003). Respiratory infections were noted in (37%) of the HAART-treated patients, and most (67%) occurred in smokers. CATMOD analyses controlling for HAART, viral load and CD4, indicated that HIV-infected smokers were three times more likely to be hospitalized with PCP and twice as likely to be hospitalized with community-acquired pneumonia than non-smokers, with increased risk related to the number of cigarettes/day in a dose-dependent manner. Conclusions: Tobacco use, which is widespread among HIV-infected subjects, increases the risk of pulmonary diseases, particularly PCP and CAP, two respiratory infections with high prevalence and morbidity risks even in the era of HAART. © 2005 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

publication date

  • July 1, 2005

Digital Object Identifier (DOI)

start page

  • 208

end page

  • 217


  • 9


  • 4